Diffuse alveolar damage

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Diffuse alveolar damage
Hyaline membranes in diffuse alveolar damage
Synonyms	DAD
Pronounce	N/A
Specialty	Pulmonology, Pathology
Symptoms	Acute respiratory distress syndrome, Hypoxemia, Dyspnea
Complications	Respiratory failure, Pulmonary fibrosis
Onset	Acute
Duration	Variable
Types	N/A
Causes	Sepsis, Trauma, Pneumonia, Aspiration, Inhalation injury
Risks	Mechanical ventilation, Severe infection, Shock (circulatory), Multiple organ dysfunction syndrome
Diagnosis	Chest X-ray, CT scan, Lung biopsy
Differential diagnosis	Pulmonary edema, Interstitial lung disease, Pneumonitis
Prevention	N/A
Treatment	Supportive care, Mechanical ventilation, Corticosteroids
Medication	N/A
Prognosis	Variable, often poor
Frequency	Common in intensive care unit settings
Deaths	N/A

Hyaline membranes in diffuse alveolar damage

The normal alveolus and the injured alveolus in acute diffuse alveolar damage

Diffuse Alveolar Damage (DAD) is a pathological condition characterized by damage to the alveoli, which are the small air sacs in the lungs where gas exchange occurs. It is a major histopathological pattern observed in Acute Respiratory Distress Syndrome (ARDS), a severe form of lung injury that can result from a variety of causes, including infection, trauma, pneumonia, and sepsis. DAD is considered the initial phase of ARDS and is critical in the progression of the disease.

Etiology

The causes of Diffuse Alveolar Damage are varied and often involve direct or indirect injury to the lung. Direct causes include inhalation of toxic substances, pneumonia, and aspiration of gastric contents. Indirect causes are systemic and include sepsis, severe trauma, and pancreatitis. The common pathway in DAD is an intense inflammatory response that leads to damage of the alveolar walls.

Pathophysiology

The pathophysiology of DAD involves three phases: the exudative phase, the proliferative phase, and the fibrotic phase.

• The exudative phase occurs within the first week and is characterized by the leakage of protein-rich fluid into the alveoli, leading to the formation of hyaline membranes. This phase is marked by significant inflammation and edema that disrupt gas exchange.
• The proliferative phase follows, characterized by the proliferation of type II pneumocytes and fibroblasts, which attempt to repair the alveolar epithelium. During this phase, the lung architecture begins to be restored, but the process can also lead to abnormal repair and fibrosis.
• The fibrotic phase is the final stage, where excessive fibrosis can lead to irreversible lung damage and decreased lung function.

Clinical Features

Patients with DAD typically present with rapid onset of respiratory failure. Symptoms include severe shortness of breath, hypoxemia (low blood oxygen levels), and cyanosis. The diagnosis is often made in the context of the underlying condition leading to ARDS and is supported by imaging studies, such as chest X-rays or CT scans, which show diffuse pulmonary infiltrates.

Diagnosis

Diagnosis of DAD is primarily based on clinical presentation and history of risk factors. Imaging studies are crucial for diagnosis, with chest X-rays and CT scans showing diffuse bilateral infiltrates. In some cases, a lung biopsy may be performed to confirm the diagnosis, revealing the characteristic histological features of DAD.

Treatment

Treatment of DAD focuses on addressing the underlying cause and supporting the patient with respiratory support. This may include mechanical ventilation with low tidal volumes and high positive end-expiratory pressure (PEEP) to improve oxygenation while minimizing further lung injury. Management of the underlying cause, whether it be infection, trauma, or another condition, is critical. Supportive care, including fluid management and nutritional support, is also important.

Prognosis

The prognosis of patients with DAD varies and depends on the severity of the initial injury, the underlying cause, and the presence of comorbidities. Despite advances in supportive care, the mortality rate remains high, particularly in severe cases.

   This article is a medical stub. You can help WikiMD by expanding it!